Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua C Cyktor

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ARTAnn Wiegand, Jonathan Spindler, Feiyu F Hong, et al.
The Journal of Infectious Diseases|April 5, 2022
Reply to Bottanelli et alJoshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
The Journal of Infectious Diseases|July 1, 2020
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral TherapyJoshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
Science Advances|February 4, 2026
Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptorSeungmin Shin, Yae-Jin Kim, Bernard J C Macatangay, et al.
Open Forum Infectious Diseases|October 2, 2025
Intact and Defective HIV Provirus Changes During Antiretroviral Therapy in People Treated During Acute or Chronic HIV Infection or as HIV ControllersRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.
Plos Pathogens|April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activationRajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2020
Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral TherapyChristina Mallarino-Haeger, Kaleab Z Abebe, Edwin K Jackson, et al.
Open Forum Infectious Diseases|October 27, 2018
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ARTSharon A Riddler, Lu Zheng, Christine M Durand, et al.
The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.
The Journal of Infectious Diseases|February 10, 2023
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral TherapyRajesh T Gandhi, Ronald J Bosch, Hanna Mar, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2017
Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ARTAnn Wiegand, Jonathan Spindler, Feiyu F Hong, et al.
The Journal of Infectious Diseases|April 5, 2022
Reply to Bottanelli et alJoshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
The Journal of Infectious Diseases|July 1, 2020
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral TherapyJoshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
Science Advances|February 4, 2026
Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptorSeungmin Shin, Yae-Jin Kim, Bernard J C Macatangay, et al.
Open Forum Infectious Diseases|October 2, 2025
Intact and Defective HIV Provirus Changes During Antiretroviral Therapy in People Treated During Acute or Chronic HIV Infection or as HIV ControllersRajesh T Gandhi, Joshua C Cyktor, Ronald J Bosch, et al.
Plos Pathogens|April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activationRajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2020
Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral TherapyChristina Mallarino-Haeger, Kaleab Z Abebe, Edwin K Jackson, et al.
Open Forum Infectious Diseases|October 27, 2018
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ARTSharon A Riddler, Lu Zheng, Christine M Durand, et al.
The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.
The Journal of Infectious Diseases|February 10, 2023
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral TherapyRajesh T Gandhi, Ronald J Bosch, Hanna Mar, et al.
Pageof 4